Patient Portal

Paul Glaser, MD, PhD

Professor, Psychiatry
Director, Adolescent Substance Use Education

Specialty Areas

Child and Adolescent Psychiatry

Hospital Affiliations

St. Louis Children's Hospital
Barnes-Jewish Hospital

Areas of Clinical Interest

Adolescent substance use, developmental disorders in children, psychopharmacology of ADHD

  • Education
  • Publication & Research



Medical Degree / PhD: Washington University School of Medicine, St. Louis, Missouri 1996
Master of Science: University of Chicago, Chicago, Illinois 1986
Bachelor of Science: University of Chicago, Chicago, Illinois 1986
Residency / Fellowship: Pediatrics / Adult Psychiatry / Child Psychiatry University of Kentucky, Lexington Kentucky 2001

Publication & Research

Publication & Research

Lile JA, Stoops WW, Rush CR, Negus SS, Glaser PE, Hatton KW, Hays LR, (2016 Aug). Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug Alcohol Depend. 165: 111-9.  

Miller EM, Quintero JE, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE (2015 Aug 30). Simultaneous glutamate recordings in the frontal cortex network with multisite biomorphic microelectrodes: New tools for ADHD research. J Neurosci Methods. 25275-9.  

Stoops WW, Pike E, Hays LR, Glaser PE, Rush CR (2015 Feb). Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine. Pharmacol Biochem Behav. 12945-50.  

Pike E, Stoops WW, Hays LR, Glaser PE, Rush CR (2014 Dec). Methamphetamine self-administration in humans during D-amphetamine maintenance. J Clin Psychopharmacol. 34(6): 675-81.  

Miller EM, Pomerleau F, Huettl P, Gerhardt GA, Glaser PE (2014 Aug). Aberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder. Psychopharmacology (Berl). 231(15): 3019-29.  

Pornnoppadol C, Friesen DS, Haussler TS, Glaser PE, Todd RD (1999). No difference between platelet serotonin--5-HT(2A) receptors from children with and without ADHD. J Child Adolesc Psychopharmacol. 9(1): 27-33.  

Areas of Research Interest

The prevention of adolescent substance use, the treatment of adolescent substance use, and the neuropsychopharmacology of ADHD, stimulant, and non-stimulant medications